Xconomy’s Digital Events →
Rob Knight of UC San Diego describes the enormous impact of tiny microbes.
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.